222 related articles for article (PubMed ID: 7563575)
1. Altered platelet activating factor metabolism in insulin dependent diabetes mellitus.
Memon RA; Saeed SA; Jabbar A; Jafri A; Gilani AH; Saleem S; Akbani H
J Pak Med Assoc; 1995 May; 45(5):122-5. PubMed ID: 7563575
[TBL] [Abstract][Full Text] [Related]
2. Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment.
Kudolo GB; Bressler P; DeFronzo RA
J Lipid Mediat Cell Signal; 1997 Nov; 17(2):97-113. PubMed ID: 9459136
[TBL] [Abstract][Full Text] [Related]
3. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.
Stafforini DM; McIntyre TM; Carter ME; Prescott SM
J Biol Chem; 1987 Mar; 262(9):4215-22. PubMed ID: 3549727
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor acetylhydrolase in human seminal plasma.
Letendre ED; Miron P; Roberts KD; Langlais J
Fertil Steril; 1992 Jan; 57(1):193-8. PubMed ID: 1730316
[TBL] [Abstract][Full Text] [Related]
5. Significance of platelet-activating factor acetylhydrolase in patients with non-insulin-dependent (type 2) diabetes mellitus.
Serban M; Tanaseanu C; Kosaka T; Vidulescu C; Stoian I; Marta DS; Tanaseanu S; Moldoveanu E
J Cell Mol Med; 2002; 6(4):643-7. PubMed ID: 12611648
[TBL] [Abstract][Full Text] [Related]
6. Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus.
Kujiraoka T; Iwasaki T; Ishihara M; Ito M; Nagano M; Kawaguchi A; Takahashi S; Ishi J; Tsuji M; Egashira T; Stepanova IP; Miller NE; Hattori H
J Lipid Res; 2003 Oct; 44(10):2006-14. PubMed ID: 12867534
[TBL] [Abstract][Full Text] [Related]
7. [Positive and negative effects of progestins on platelet-activating factor acetylhydrolase activity in rat plasma].
Fujikami F; Yasuda K; Sawaragi I
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jun; 47(6):539-46. PubMed ID: 7608617
[TBL] [Abstract][Full Text] [Related]
8. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers.
Imaizumi T; Satoh K; Yoshida H; Kawamura Y; Hiramoto M; Koyanagi M; Takamatsu S; Takamatsu M
Heart Vessels; 1990; 5(2):81-6. PubMed ID: 2354992
[TBL] [Abstract][Full Text] [Related]
9. The contribution of individual lipoproteins to the degradation of platelet-activating factor in human serum.
Ostermann G; Kostner GM; Gries A; Malle E; Till U
Haemostasis; 1989; 19(3):160-8. PubMed ID: 2744632
[TBL] [Abstract][Full Text] [Related]
10. Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and reduced lipoprotein-associated platelet-activating factor acetylhydrolase activity.
Tselepis AD; Elisaf M; Besis S; Karabina SA; Chapman MJ; Siamopoulou A
Arthritis Rheum; 1999 Feb; 42(2):373-83. PubMed ID: 10025933
[TBL] [Abstract][Full Text] [Related]
11. [A simple measurement of plasma platelet-activating factor (PAF) acetylhydrolase, normal level of activity, and distribution among lipoprotein fractions].
Kawamura Y; Satoh K; Takamatsu S; Mizuno S
Rinsho Byori; 1987 Oct; 35(10):1149-53. PubMed ID: 3437547
[No Abstract] [Full Text] [Related]
12. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.
Ambrosio G; Oriente A; Napoli C; Palumbo G; Chiariello P; Marone G; Condorelli M; Chiariello M; Triggiani M
J Clin Invest; 1994 Jun; 93(6):2408-16. PubMed ID: 8200975
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor acetylhydrolase activity in bovine seminal plasma.
Parks JE; Hough SR
J Androl; 1993; 14(5):335-9. PubMed ID: 8288488
[TBL] [Abstract][Full Text] [Related]
14. Altered platelet-activating factor levels and acetylhydrolase activities are associated with increasing severity of bronchopulmonary dysplasia.
Gaylord MS; Smith ZL; Lorch V; Blank ML; Snyder F
Am J Med Sci; 1996 Oct; 312(4):149-54. PubMed ID: 8853062
[TBL] [Abstract][Full Text] [Related]
15. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease.
Satoh K; Imaizumi T; Kawamura Y; Yoshida H; Takamatsu S; Mizono S; Shoji B; Takamatsu M
Prostaglandins; 1988 May; 35(5):685-98. PubMed ID: 3399678
[TBL] [Abstract][Full Text] [Related]
16. Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases.
Dulioust A; Hilliquin P; Menkes CJ; Benveniste J; Arnoux B
Scand J Rheumatol; 1992; 21(4):161-4. PubMed ID: 1529281
[TBL] [Abstract][Full Text] [Related]
17. Increased blood levels of platelet-activating factor in insulin-dependent diabetic patients with microalbuminuria.
Cavallo-Perin P; Lupia E; Gruden G; Olivetti C; De Martino A; Cassader M; Furlani D; Servillo L; Quagliuolo L; Iorio E; Boccellino MR; Montrucchio G; Camussi G
Nephrol Dial Transplant; 2000 Jul; 15(7):994-9. PubMed ID: 10862637
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor acetylhydrolase increases during macrophage differentiation. A novel mechanism that regulates accumulation of platelet-activating factor.
Elstad MR; Stafforini DM; McIntyre TM; Prescott SM; Zimmerman GA
J Biol Chem; 1989 May; 264(15):8467-70. PubMed ID: 2722780
[TBL] [Abstract][Full Text] [Related]
19. Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase.
Tsironis LD; Mitsios JV; Milionis HJ; Elisaf M; Tselepis AD
Cardiovasc Res; 2004 Jul; 63(1):130-8. PubMed ID: 15194469
[TBL] [Abstract][Full Text] [Related]
20. Serum PAF-acetylhydrolase in severe renal or hepatic disease in man: relationship to circulating levels of PAF and effects of nephrectomy or transplantation.
Meade CJ; Birke F; Metcalfe S; Watson C; Jamieson N; Neild G
J Lipid Mediat Cell Signal; 1994 May; 9(3):205-15. PubMed ID: 7921780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
